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Abstract
Yawning continues to pose as a scientist’s conundrum.
Evidence is presented of yawning and contagious yawning
in a number of different neurological disorders.
Explanations are discussed in the context of disparate
neurological disorders together with proposals for how
these findings may be linked. Thus, greater understanding
of yawning and of neurological disorders may be achieved
by exploring common neuro-chemical pathways and the
involvement of neurotransmitters that are implicated in
these different disorders. Finally, contagious yawning is
discussed in the context of the susceptibility of persons
and the similarity this presents with our understanding of
the mechanisms involved in hypnosis.
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Introduction
The term ‘biological marker’ or ‘biomarker’ dates back to
1980 (Aronson, 2005) and is defined as an entity that
measures a particular biological state, objectively measured
and evaluated as an indicator of normal biological processes,
pathogenic processes or pharmacological responses to a
therapeutic intervention [1].
Historically, a large number of people are selected from a
given disease category to identify the biomarker. Following this
‘proof of concept’, experimental validation takes place using
various methods, for example, histology, and then followed by
analytical validation exploring several parameters: sensitivity;
specificity; robustness; accuracy; and reproducibility [2].
Cortisol is a naturally occurring hormone that is considered
important for immune protection and stress regulation [3-5]
(Figure 1). Measuring the levels of cortisol is useful for
monitoring a number of different medical conditions including
cases where high levels of stress are known such as adrenal
insufficiency, or Cushing’s disease, and for certain neurological
diseases, including multiple sclerosis [6].
The link between assay levels obtained via invasive blood
collection and non-invasive, saliva sampling is directly
proportional to the serum unbound cortisol concentration
both in normal women and men [7].
Figure 1 Cortisol hormone showing atoms and bonds.
A greater level of neuromuscular fatigue and larger
responses in serum hormone concentrations has been
evidenced after hypertrophic variable resistance loadings [8].
This has led to identifying markers of fatigue [9]; in particular,
following post-match professional rugby [10] and also in young
elite athletes [11], and in elite tennis players [12].
Tiredness due to physical exercise and even mental
concentration on tasks is often referred to as ‘fatigue’ and is
sometimes associated with yawning. The Thompson Cortisol
Hypothesis [13] is the first evidence-based report that links
cortisol, with yawning, and demonstrates that cortisol rises
when we yawn. A common symptom of multiple sclerosis (MS)
is fatigue [14] which is also associated with excessive yawning
and a rise in brain temperature, governed by the
hypothalamus [15].
Temperature regulation and circadian rhythm is the
responsibility of the hypothalamus which is intimately linked
to two other body structures, the pituitary gland and the
adrenal glands which secrete adrenaline. Typically, the
hypothalamus-pituitary-adrenal (HPA) axis produces sufficient
hormones to protect against stress and ensures the body is
ready for physical activity.
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Produced by the zona fasciculate of the adrenal cortex [16],
the rise in cortisol level possibly triggers the response to yawn
and in turn, lowers the temperature of the brain [17-19].
The author’s team at Bournemouth University and the
French teams at Amiens University Hospital and the University
of Picardy Jules Verne [20] tested the theory that intrinsic and
phasic fatigue may be associated with cortisol levels and that
yawning, known to be associated with elevated cortisol levels
[6], may occur in association with fatigue. This could explain
why people with multiple sclerosis yawn when they are
frequently fatigued.
The role of cortisol in mental and motor tasks together with
the recruitment of brain regions during these tasks has been
explored in a recent fMRI study [20]. In healthy participants,
cortisol levels were found to be higher and had greater
reduction in levels during mental versus motor tasks. These
findings also showed that recruitment of brain-stem and
hypothalamus regions, which are considered to be important
in cortisol activity, were affected to differing extents.
For example, at low cortisol levels, mental task participants
had less activity in the regions than their physical task
counterparts and when cortisol levels were higher, wider
spread recruitment of these brain regions was seen in the
mental task participants. For the physical task participants, the
spread was at comparative low levels of cortisol.
These encouraging and intriguing results are yet to be seen
in people with immune-suppression, neurological disease, and
cortisol insufficiency. However, if cortisol is implicated in these
brain regions, this tends to lend support for the Thompson
Cortisol Hypothesis. Furthermore, it suggests that brain region
recruitment is likely to be dependent upon cortisol levels as
well as perception of stress in a task. It is suggested that the
mental tasks in this study were perceived as being more
stressful than the physical tasks but demanded higher cortisol
levels to promote wider spread brain region activity.
Cortisol, together with fatigue-related yawning may provide
scientists and neurologists with a new biomarker of underlying
neurological disease. As with any potential and new
biomarkers, the systematic evaluation of healthy and non-
healthy participants needs to be carried out but it does
present us with considerable new possibilities for the
detection, and perhaps early intervention of multiple sclerosis
in the near future.
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